Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Resl

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Wiener Klinische Wochenschrift|April 26, 2023
[Obesity and type 2 diabetes (Update 2023)]Martin Clodi, Hermann Toplak, Michael Resl, et al.
European Journal of Preventive Cardiology|August 23, 2011
A comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitusMartin Clodi, Michael Resl, Stephanie Neuhold, et al.
Journal of the American College of Cardiology|July 2, 2013
PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trialMartin Huelsmann, Stephanie Neuhold, Michael Resl, et al.
Diabetes Care|July 1, 2009
Endothelial markers may link kidney function to cardiovascular events in type 2 diabetesChristina Maier, Martin Clodi, Stephanie Neuhold, et al.
Heart (British Cardiac Society)|May 27, 2016
Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profilesRaphael Wurm, Michael Resl, Stephanie Neuhold, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Hospital diabetes management (Update 2023)]Julia K Mader, Johanna M Brix, Felix Aberer, et al.
Journal of Cellular and Molecular Medicine|November 23, 2022
Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers - A prospective cross-over trialJohannes Pohlhammer, Matthias Wolfgang Heinzl, Carmen Klammer, et al.
Cardiovascular Diabetology|February 3, 2021
Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitusSuriya Prausmüller, Michael Resl, Henrike Arfsten, et al.
Journal of Clinical Medicine|December 17, 2024
High-Density Lipoprotein Predicts Intrahospital Mortality in InfluenzaMatthias Wolfgang Heinzl, Markus Freudenthaler, Paul Fellinger, et al.
Journal of Diabetes Science and Technology|May 23, 2026
Smart Pens: Expectations Regarding Use and Functionality From Health Care ProvidersJulia K Mader, Lutz Heinemann, Derek Brandt, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Wiener Klinische Wochenschrift|April 26, 2023
[Obesity and type 2 diabetes (Update 2023)]Martin Clodi, Hermann Toplak, Michael Resl, et al.
European Journal of Preventive Cardiology|August 23, 2011
A comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitusMartin Clodi, Michael Resl, Stephanie Neuhold, et al.
Journal of the American College of Cardiology|July 2, 2013
PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trialMartin Huelsmann, Stephanie Neuhold, Michael Resl, et al.
Diabetes Care|July 1, 2009
Endothelial markers may link kidney function to cardiovascular events in type 2 diabetesChristina Maier, Martin Clodi, Stephanie Neuhold, et al.
Heart (British Cardiac Society)|May 27, 2016
Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profilesRaphael Wurm, Michael Resl, Stephanie Neuhold, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Hospital diabetes management (Update 2023)]Julia K Mader, Johanna M Brix, Felix Aberer, et al.
Journal of Cellular and Molecular Medicine|November 23, 2022
Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers - A prospective cross-over trialJohannes Pohlhammer, Matthias Wolfgang Heinzl, Carmen Klammer, et al.
Cardiovascular Diabetology|February 3, 2021
Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitusSuriya Prausmüller, Michael Resl, Henrike Arfsten, et al.
Journal of Clinical Medicine|December 17, 2024
High-Density Lipoprotein Predicts Intrahospital Mortality in InfluenzaMatthias Wolfgang Heinzl, Markus Freudenthaler, Paul Fellinger, et al.
Journal of Diabetes Science and Technology|May 23, 2026
Smart Pens: Expectations Regarding Use and Functionality From Health Care ProvidersJulia K Mader, Lutz Heinemann, Derek Brandt, et al.
Pageof 7